- Home
- GUTS vs SER Comparison
GUTS vs SER Comparison
Compare GUTS & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GUTS
- SER
- Stock Information
- Founded
- GUTS 2010
- SER 2017
- Country
- GUTS United States
- SER United States
- Employees
- GUTS N/A
- SER N/A
- Industry
- GUTS
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- GUTS
- SER Health Care
- Exchange
- GUTS NYSE
- SER Nasdaq
- Market Cap
- GUTS 58.9M
- SER 47.5M
- IPO Year
- GUTS 2024
- SER 2018
- Fundamental
- Price
- GUTS $1.16
- SER $5.33
- Analyst Decision
- GUTS Buy
- SER Strong Buy
- Analyst Count
- GUTS 1
- SER 1
- Target Price
- GUTS $10.00
- SER $11.00
- AVG Volume (30 Days)
- GUTS 201.2K
- SER 9.7K
- Earning Date
- GUTS 03-03-2025
- SER 03-24-2025
- Dividend Yield
- GUTS N/A
- SER N/A
- EPS Growth
- GUTS N/A
- SER N/A
- EPS
- GUTS N/A
- SER N/A
- Revenue
- GUTS $93,000.00
- SER $56,000.00
- Revenue This Year
- GUTS N/A
- SER N/A
- Revenue Next Year
- GUTS N/A
- SER N/A
- P/E Ratio
- GUTS N/A
- SER N/A
- Revenue Growth
- GUTS N/A
- SER N/A
- 52 Week Low
- GUTS $1.16
- SER $3.81
- 52 Week High
- GUTS $7.89
- SER $14.57
- Technical
- Relative Strength Index (RSI)
- GUTS 35.75
- SER 54.97
- Support Level
- GUTS $1.19
- SER $4.60
- Resistance Level
- GUTS $1.32
- SER $5.82
- Average True Range (ATR)
- GUTS 0.09
- SER 0.40
- MACD
- GUTS 0.00
- SER 0.10
- Stochastic Oscillator
- GUTS 9.09
- SER 55.81
About GUTS FRACTYL HEALTH INC
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.